Displaying 2761 - 2780 of 4794
1412002 Informal Interpretation
Date
Rule
Pharma License
we have made a distinction between a licensee having the exclusive right to the drug for a specific indication or therapeutic area with the licensor retaining the right to the same drug for other...
File
Original Image File
(199.93 KB)
1412003 Informal Interpretation
Date
Rule
802.64
- looking back to the SBP for the 1978 Final Rule 802.64, it appears that the type of entity you are describing was specifically excluded from the exemption: "Partnerships holding voting securities...
File
Original Image File
(94.85 KB)
1412001 Informal Interpretation
Date
Rule
REIT
We can't blink on this one. The rule says "No new assets will be contributed to the new entity as a result of the conversion". We have stretched that to say that if only cash is introduced, you can...
File
Original Image File
(335.92 KB)
FTC Staff Urges Dental Accreditation Commission To Adopt Dental Therapy Accreditation Standards
Date
Federal Trade Commission staff submitted comments to Dr. Sherin Tooks, Director of the Commission on Dental Accreditation (CODA), urging CODA to finalize and adopt accreditation standards for dental...
FTC Puts Conditions on Medtronic’s Proposed Acquisition of Covidien
Date
Global medical technology company Medtronic, Inc. has agreed to divest the drug-coated balloon catheter business of Ireland-based medical products company Covidien plc, in order to settle Federal...
FTC Puts Conditions on Pharmaceutical Joint Venture Between GlaxoSmithKline and Novartis
Date
Global pharmaceutical company Novartis AG has agreed to divest Habitrol, its nicotine replacement therapy patch, to settle FTC charges that its consumer health care products joint venture with...
FTC Issues Agency Financial Report for Fiscal Year 2014
Date
The FTC’s AFR provides an overview of fiscal and key performance results that show how the agency has managed its resources.
Nov07
100th Anniversary Symposium
For 100 years, the Federal Trade Commission has distinguished itself as a unique and nimble institution. The FTC continually evolves and innovates to promote competition and protect consumers. Please...
Dissenting Statement of Commissioner Maureen K. Ohlhausen - In the Matter of AmeriGas and Blue Rhino
Date
By
Maureen K. Ohlhausen, Former Commissioner
FTC Requires Divestiture as a Condition of Surgery Center Holdings' Acquisition of Competitor Symbion
Date
The Federal Trade Commission will require Surgery Center Holdings, Inc., known as Surgery Partners, and Symbion Holdings Corporation to divest Symbion’s ownership interest in an ambulatory surgery...
Blue Rhino, AmeriGas Settle FTC Charges of Restraining Competition
Date
The two leading suppliers of propane exchange tanks, Blue Rhino and AmeriGas Cylinder Exchange, have agreed to settle FTC charges that the companies illegally agreed not to deviate from their plans to...
FTC Requests Public Comments on SCI’s Application to Approve Sale of Funeral Home in Auburn, California
Date
The Federal Trade Commission is currently accepting public comments on an application by Service Corporation International (SCI) to sell a funeral home located in Auburn, California, as required under...
FTC Requests Public Comments on Graco’s Application for Approval to Divest Liquid Finishing Business Assets to Carlisle Companies
Date
The Federal Trade Commission is currently accepting public comments on an application by Graco Inc. to divest certain liquid finishing businesses and related assets to Carlisle Companies Inc. Under...
Displaying 2761 - 2780 of 4794